Chargement en cours...
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
Bazedoxifene, a novel selective estrogen receptor modulator, has been developed to have favorable effects on bone and the lipid profile while minimizing stimulation of uterine or breast tissues. Two large Phase III clinical trials showed that bazedoxifene, as well as raloxifene, increased bone miner...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3131985/ https://ncbi.nlm.nih.gov/pubmed/21753870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S15711 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|